Skip to main content
. 2019 Apr 8;10:207. doi: 10.3389/fendo.2019.00207

Figure 2.

Figure 2

Silencing FOXD2-AS1 inhibits cancer stem cell characteristics in thyroid cancer cells. (A) Real-time PCR analysis of FOXD2-AS1 expression in normal thyroid follicular epithelial cells PTFE and seven thyroid cancer cells, including four PTC cell lines, B-CPAP, BHT101, KTC-1 and K1, and two ATC cell lines, CAL-62, and 8305C, and one thyroid duct cell carcinoma cells, TT. GAPDH was used as endogenous controls. *P < 0.05. (B) FOXD2-AS1 expression in the scramble, FOXD2-AS1 shRNA#1 and FOXD2-AS1 shRNA#2 thyroid cancer cells using real-time PCR. Transcript levels were normalized by GAPDH expression. *P < 0.05. (C) Representative images of spheroids formed by the scramble, FOXD2-AS1 shRNA#1 and FOXD2-AS1 shRNA#2 thyroid cancer cells at 200-fold magnification were counted. Histograms showed the mean number of spheroids formed. *P < 0.05. (D) The effect of silencing FOXD2-AS1 on side population in the indicated thyroid cancer cells by Hoechst 33342 dye exclusion assay. Histograms showed the fraction of side population in thyroid cancer cells.*P < 0.05. (E) The effect of silencing FOXD2-AS1 on the CD133+ population in the indicated thyroid cancer cells by flow cytometric analysis. Histograms showed the CD133+ percentage of thyroid cancer cells. *P < 0.05. (F,G) The effect of silencing FOXD2-AS1 on multiple stemness markers, including ABCG2, SOX2, NANOG, BMI-1, ALHD1A1, POU5F1, and KLF4, by real-time PCR analysis in the indicated thyroid cancer cells. Transcript levels were normalized by GAPDH expression. *P < 0.05. (H) The effect of silencing FOXD2-AS1 on ABCG2, SOX2, NANOG, and BMI-1 by Western blot in the indicated thyroid cancer cells. α-Tubulin was detected as a loading control.